跳至主要内容
临床试验/IRCT20200616047792N1
IRCT20200616047792N1招募中未知

Study of intra-venous ozonated auto-hemotherapy on severe cases of COVID-19: A randomized clinical trial

Ahvaz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • Severe cases of Covid-19 with chest CT changes in the form of peripheral uni- or bilateral ground glass opacity(s) in combination with any of the below: RR greater than 24, O2 Sat less than 93%, BP less than 90/60, decreased level of consciousness.

排除标准

  • G6PD Deficiency
  • Coagulopathies and thrombocytopenia
  • Hx of seizure
  • Hypothyroidism
  • Pancreatitis
  • Hemophilias
  • Acute alcohol poisoning
  • Pregnancy and breast feeding
  • Allergy to ozone and ozonated products

研究者

相似试验